Second Genome and Mayo Clinic Enter Collaboration to Develop Microbiome Therapeutics in Multiple Diseases

October 7, 2014, South San Francisco, CA

Read More

Second Genome Appoints Karim Dabbagh, Ph.D., as Chief Scientific Officer

September 2, 2014, South San Francisco, CA

Read More

Second Genome Enters Into Agreement with Pfizer Inc. on Microbiome Research Initiative in Obesity

May 2, 2014, South San Francisco, CA

Read More

Second Genome Announces Agreement with Janssen on Microbiome Drug Discovery in Ulcerative Colitis

June 5, 2013, San Bruno, CA

Read More

Second Genome Sponsors American Gut Initiative to Identify Links Between Type 2 Diabetes and the Human Microbiome

January 3, 2013, San Francisco, CA

Read More

Second Genome Presents Preclinical Research on the Impact of the Microbiome on C. difficile Infection

November 2, 2012, San Bruno, CA

Read More

Second Genome Announces Human Microbiome Project Publications

June 13, 2012, San Bruno, CA

Read More

Second Genome Announces Expansion of Scientific Advisory Board

March 31, 2012, San Bruno, CA

Read More